Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety

BACKGROUND: Chronic migraine is associated with significant headache-related disability and psychiatric comorbidity. OnabotulinumtoxinA (BOTOX(®)) is effective and well tolerated in the prophylactic treatment of chronic migraine. This study aimed to provide preliminary data on the efficacy and safet...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Gen Med
Main Authors: Boudreau, Guy P, Grosberg, Brian M, McAllister, Peter J, Lipton, Richard B, Buse, Dawn C
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4340374/
https://ncbi.nlm.nih.gov/pubmed/25733924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S70456
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki